The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S, and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
本发明涉及抑制半胱
氨酸
蛋白酶的化合物,特别是对于cathepsin B、K、L、F和S,因此这些化合物对于治疗由这些
蛋白酶介导的疾病是有用的。本发明涉及包含这些化合物的制药组合物和制备它们的过程。